|
|
||||||||
1Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15260; and 2Department of Pediatrics, University of Rochester, Rochester, New York 14620
Submitted 1 June 2004 ; accepted in final form 28 July 2004
Identification of early events that contribute to the establishment of chronic lung disease has been complicated by the variable involvement of the airway and alveolar compartments in the complex physiology of end-stage disease. In particular, the impact of airway injury on alveolar integrity and function has not been addressed and would be facilitated by development of animal models of lung disease that specifically target a single cell type within the airway epithelium. We have previously demonstrated that ganciclovir treatment of CCtk transgenic mice, which express the herpes simplex thymidine kinase gene under regulation of the mouse Clara cell secretory protein (CCSP) promoter, results in elimination of the airway progenitor and stem cell pools and a consequent failure of airway regeneration that is associated with rapid morbidity and mortality. In this study, we used the CCtk model to test the hypothesis that selective airway injury initiates profound lung dysfunction through mechanisms that compromise alveolar integrity. Results demonstrate that elimination of the CCSP-expressing cell population results in secondary alveolar inflammation, edema, and depletion of the alveolar type II cell population. On the basis of these data we conclude that selective airway injury can serve as the inciting injury in diseases characterized by severely compromised alveolar function.
Clara cell secretory protein; herpes simplex thymidine kinase gene; transgenic mice; surfactant protein C; ganciclovir; lung injury; repair; chronic lung disease; asthma
This article has been cited by other articles:
![]() |
J. S. Dovey, S. J. Zacharek, C. F. Kim, and J. A. Lees Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion PNAS, August 19, 2008; 105(33): 11857 - 11862. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Warburton, L. Perin, R. DeFilippo, S. Bellusci, W. Shi, and B. Driscoll Stem/Progenitor Cells in Lung Development, Injury Repair, and Regeneration Proceedings of the ATS, August 15, 2008; 5(6): 703 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Rippon, S. Lane, M. Qin, N.-S. Ismail, M. R. Wilson, M. Takata, and A. E. Bishop Embryonic Stem Cells as a Source of Pulmonary Epithelium In Vitro and In Vivo Proceedings of the ATS, August 15, 2008; 5(6): 717 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Wong, A. E. Dutly, A. Sacher, H. Lee, D. M. Hwang, M. Liu, S. Keshavjee, J. Hu, and T. K. Waddell Targeted cell replacement with bone marrow cells for airway epithelial regeneration Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L740 - L752. [Abstract] [Full Text] [PDF] |
||||
![]() |
C M Doerschuk Circulating endothelial progenitor cells in pulmonary inflammation Thorax, May 1, 2005; 60(5): 362 - 364. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |